Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder, Frank J M Beurskens, Rob N. de Jong et al. · Science · 2014
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feature of natural immune defense, a number of disease processes, and immunotherapies. How antibodies activate the complement cascade, however, is poorly understood. We found that specific noncovalent interactions between Fc segments of immunoglobulin G (IgG) antibodies resulted in the formation of ordered antibody hexamers after antigen binding on cells. These hexamers recruited and activated C1, the first component of complement, thereby triggering the complement cascade. The interactions between neighboring Fc segments could be manipulated to block, reconstitute, and enhance complement activation and killing of target cells, using all four human IgG subclasses. We offer a general model for understanding antibody-mediated complement activation and the design of antibody therapeutics with enhanced efficacy.
Cited by 796 works. doi:10.1126/science.1248943
Authors
- Christoph A. Diebolder
- Frank J M Beurskens
- Rob N. de Jong
- Roman I. Koning
- Kristin Strumane
- Margaret A. Lindorfer
- Marleen Voorhorst
- Deniz Ugurlar
- Sara Rosati
- Albert J. R. Heck
- Jan G. J. van de Winkel
- Ian A. Wilson
- Abraham J. Koster
- Ronald P. Taylor
- Erica Ollmann Saphire
- Dennis R. Burton
- Janine Schuurman
- Piet Gros
- Paul W.H.I. Parren
References
- UCSF Chimera—A visualization system for exploratory research and analysis
- Computer Visualization of Three-Dimensional Image Data Using IMOD
- Iterative methods for the three-dimensional reconstruction of an object from projections
- SPIDER and WEB: Processing and Visualization of Images in 3D Electron Microscopy and Related Fields
- Complement: a key system for immune surveillance and homeostasis
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
- Complement Fixation on Cell Surfaces by 19 S and 7 S Antibodies
- Dual-Axis Tomography: An Approach with Alignment Methods That Preserve Resolution
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- Immunoglobulin G: Functional sites